Sonoma Pharmaceuticals, Inc. — Director's Dealing 2012

Dec 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2012-12-07

Reporting Person: Alimi Hojabr (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-07	Common Stock	P	1000	$0.65	Acquired	1026750	Direct
2012-12-07	Common Stock	P	2000	$0.6476	Acquired	1028750	Direct
2012-12-07	Common Stock	P	2200	$0.6489	Acquired	1030950	Direct
2012-12-07	Common Stock	P	100	$0.65	Acquired	1031050	Direct

Footnotes

F1: Mr. Alimi purchased these shares in the open market.

F2: Mr. Alimi beneficially owns these shares of common stock in joint ownership with his wife, Linda Alimi, with whom he shares voting and dispositive control.

F3: This amount includes an aggregate of 5,500 shares of common stock purchased in the open market on December 10, 2012 and reported on a Form 4 filed that same date.